|
|
Article: Amicus Therapeutics Files For Initial Public Offering.
- Article from:
- PR Newswire
- Article date:
- March 30, 2007
CopyrightCOPYRIGHT 2007 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
CRANBURY, N.J., March 30 /PRNewswire/ -- Amicus Therapeutics, Inc. today announced that it has filed a registration statement with the Securities and Exchange Commission (SEC) relating to the proposed initial public offering of shares of its common stock. All shares in the offering will be sold by Amicus Therapeutics.
The underwriters for the offering are led by Morgan Stanley & Co. Incorporated and Merrill Lynch & Co., as joint book-runners, with J.P. Morgan Securities Inc., Lazard Capital Markets LLC, and Pacific Growth Equities, LLC acting as co-managers. The number of shares to be offered and the price range for the offering have not yet been determined.
...